Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Acne Scars: Prevention, Early Treatment Best

J Drugs Dermatol; 2017 Feb; Tan, Kang, et al

Prevention and early treatment remain a primary strategy against acne scars, a recent study found. Researchers performed a prospective study of subjects (n=1,972) consulting a dermatologist for active acne to assess the frequency of acne scarring. They administered a short questionnaire on all acne patients examined in an office setting for 1 consecutive 5-day work week to assess scar frequency. Additionally, the first 4 subjects with acne scars identified were enrolled for a second phase (scar cohort) of the study during which further medical history was collected and a clinical evaluation performed. They found:

  • Subjects with acne scars were significantly more likely to have severe or very severe acne; however, 69% of the subjects with acne scars had mild or moderate acne at the time of the study visit.
  • Risk factors correlated with increased likelihood of scarring were acne severity, time between acne onset and first effective treatment, relapsing acne, and male gender.

Citation:

Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the United States. J Drugs Dermatol. 2017;16(2):97-102.